Sep 25, 2020: Opdivo and Keytruda are potential alternatives to current first-line therapies.

Feb 19, 2021: The new consensus guidelines apply to women who have had breast cancer in the past and were at least 75 years old.

Sep 2, 2020: Liver complications, heart disease and non-liver cancers also account for most deaths among people with hepatitis B or C.

Nov 26, 2020: Black men with breast cancer were more likely to be diagnosed at a later stage.

Dec 14, 2020: However, adjuvant chemotherapy does improve outcomes for premenopausal women with early-stage cancer that has spread to their lymph nodes.

Jan 21, 2021: Cholesterol-lowering meds may reduce cardiotoxic chemotherapy side effects in women with early breast cancer.

Jan 29, 2021: Treatment with androgen receptor inhibitors was associated with a higher likelihood of falls and fractures.

Jul 24, 2020: Draft recommendation would ensure more women and Black people meet the screening criteria.

Nov 9, 2020: Among patients with high tumor PD-L1 expression, Libtayo lowered mortality by 43%.

Oct 2, 2020: The 30% improvement in survival has brought a Phase III trial to an early halt.

Dec 21, 2020: For those with undetectable minimal residual disease, treatment discontinuation was as effective as staying on Imbruvica.

Jan 8, 2021: A Mediterranean diet could help reduce the risk of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Jul 30, 2020: The program also greatly improved patients’ satisfaction with their hospital stays.

Aug 6, 2020: Screening would be especially cost effective in high-income nations.

Sep 9, 2020: Only three states are expected to meet the 2030 goal.

Oct 30, 2020: BO-112 helped make tumor cells more vulnerable to immunotherapy, offering a possible treatment route for hard-to-treat cancers.

Oct 9, 2020: Compared with unvaccinated women, the risk among women vaccinated before age 17 dropped by almost 90%.

Nov 13, 2020: While disease progression was higher in Black men, their rates of metastasis and mortality were similar to those of white men.

Nov 23, 2020: Longer delays were associated with worsening risk of death.

Dec 8, 2020: A larger Phase II trial has been launched to evaluate the combination’s efficacy and safety.